Selank
Selank dosing, anxiolytic mechanism, side effects, and nootropic benefits. Intranasal heptapeptide reference guide.
NootropicIntranasal300mcg intranasal, 2-3 times daily
Overview
Selank (TP-7) is a synthetic heptapeptide analog of the endogenous immunomodulatory peptide tuftsin. Approved in Russia since 2009 as an intranasal anxiolytic and nootropic.
Mechanism of Action
- GABAergic modulation — Enhances GABAergic transmission without sedation
- BDNF expression — Increases brain-derived neurotrophic factor
- Enkephalin stabilization — Inhibits enkephalin degradation
- Immunomodulation — Tuftsin core provides immune-modulating effects
- No tolerance/dependence — Unlike benzodiazepines
Dosing Protocols
| Protocol | Dose | Frequency | Route | |----------|------|-----------|-------| | Standard | 300mcg | 2-3 times daily | Intranasal | | Acute anxiety | 500mcg | As needed | Intranasal |
Safety Profile
Approved and used clinically in Russia. Excellent safety profile — no sedation, tolerance, or dependence. Mild nasal irritation possible.
Last updated: 2026-03-27